In odd aftermath of FDA Commissioner Mark McClellan’s lecture, NCI Director Andrew von Eschenbach forwards the commissioner’s thank-you note to 3,000 NCI staff. The email blast follows FDA’s return of NCI’s gift to McClellan.
Also in this 8-page issue: NCI informatics project caBIG will “rapidly accelerate” cancer research, von Eschenbach says.
NCI plans 18 percent budget cuts for large R01s, smaller cuts to other research project grants. NCI treatment division director Ellen Feigal accepts position with Translational Genomics Research Institute in Phoeniz, Ariz.
In the cancer centers: San Antonio Cancer Institute gets a new director, funding commitments.
UT Health Science Center dedicates new Children’s Cancer Research Institute.
Funding opportunities listed.
Trending Stories
- Trump 2016: A look back at the 45th president’s impact on oncology
- Betty Ford and the press conference that changed oncology
- David Lauren: We’re focused on cancer. This isn’t about just sending a check. This is our mission.
- The unKOOL, unfiltered history of menthol cigarettes
- Should you eat a kielbasa tonight?
Six experts weigh evidence on papers debunking nutritional guidelines on red and processed meat - What will Trump’s return to the White House mean for oncology?
“Our work just got a lot more difficult.”
